Woodline Partners’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-532,002
Closed -$12.6M 662
2023
Q4
$12.6M Buy
532,002
+121,287
+30% +$2.86M 0.14% 202
2023
Q3
$6.12M Buy
410,715
+124,998
+44% +$1.86M 0.07% 289
2023
Q2
$3.13M Hold
285,717
0.04% 366
2023
Q1
$2.49M Buy
+285,717
New +$2.49M 0.03% 394